Velcro AAV Vector for tissue-specific delivery of genome editing reagents with enhanced cargo capacity
Velcro AAV Vector 用于基因组编辑试剂的组织特异性递送,具有增强的负载能力
基本信息
- 批准号:10001604
- 负责人:
- 金额:$ 75.82万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-01 至 2022-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAffectAnimalsAtherosclerosisBlood VesselsCRISPR/Cas technologyCapsidCardiovascular DiseasesCell surfaceCellsClinicalCre driverDNADiseaseEndothelial CellsEndotheliumEngineeringEnzymesEyeFamily suidaeFluorescenceGenesGoalsGrowthGuide RNAHarvestHumanImmune responseImmunohistochemistryIn VitroInflammationIntravenousLeucine ZippersLigandsLiverMacular degenerationMethodsMonitorMorbidity - disease rateMusOrthologous GeneOther GeneticsPECAM1 genePathologyPeptidesPhaseProductionProteinsReagentReporterReporter GenesRetinaSerotypingSignal TransductionSolid NeoplasmSomatic CellSpecificityStaphylococcus aureusStreptococcus pyogenesSurfaceSystemTechnologyTestingTimeTissuesTomatoesTransgenic MiceTranslatingTropismVariantVascular DiseasesViralViral GenomeViral VectorWestern Blottingadeno-associated viral vectorbasecell typeclinical translationcombinatorialdeep sequencingdesignexperimental studygenome editinggenotoxicityhuman diseaseimprovedin vivoin vivo evaluationintravenous administrationmortalitynanobodiesnucleasenucleic acid deliverypre-clinicalpromotersomatic cell gene editingtransduction efficiencytumor growthvector
项目摘要
PROJECT SUMMARY
Nuclease-based somatic genome editing, including approaches that use CRISPR/Cas9 and DNA Base Editor
(BE), is a transformative technology that has the potential to cure many human diseases. However, to translate
genome editing into widespread clinical use, there is an unmet need for safer and more effective technologies
to deliver genome editing machinery into disease-relevant somatic cells and tissues in vivo. Although Adeno-
Associated Viral (AAV) vectors are capable of delivering CRISPR/Cas9 systems in vivo with high editing
efficiency, they have limited packaging capacity, lack the specificity in targeting cells/tissues, and can induce
genotoxicity and immune responses due to persistent expression of Cas9. Further, most nonviral methods for
in vivo delivery of CRISPR/Cas9 using systemic administration remain ineffective. To address these
challenges, we have developed the Velcro AAV platform – AAV vectors with Leucine Zippers (LZ) inserted
strategically onto the capsid surface such that vector production and transduction efficiencies are minimally
impacted. The LZ adaptors can then be used for modular and versatile attachment of proteins onto the capsid,
such as cell-targeting nanobodies or peptides as well as genome editing reagents. Our central hypothesis is
that Velcro AAVs will provide improved cell-targeting specificity and increased packaging capacity without
affecting transduction efficiency, enabling safer and more robust somatic genome editing in vivo. During Phase
1 (UG3), Velcro AAV vectors will be constructed, characterized and optimized for nanobody-based
endothelium-targeting (Aim 1a) and Cas9/BE protein attachment (Aim 2a). The effects of nanobody/nuclease
attachment on viral titers and transduction efficiency will be quantified. Mouse studies will be carried out in
Aims 1b, 2b and 2c to test the ability of Velcro AAV vectors to specifically target the endothelium with
increased packaging capacity for gene editing in vivo. The targeting specificity and gene editing efficiency of
Velcro AAV vectors will be further determined in Phase 2 (UH3) through pig studies in Aim 3. If successful, the
proposed studies will yield strong preclinical demonstration of a new delivery platform technology that can
provide specific cell/tissue targeting, larger cargo capacity, and transient nuclease activity, enabling safe and
efficient somatic genome editing in humans.
项目摘要
基于核酸酶的体细胞基因组编辑,包括使用CRISPR/Cas9和DNA碱基编辑器的方法
(BE)是一项变革性技术,有可能治愈许多人类疾病。然而,要翻译
随着基因组编辑广泛应用于临床,对更安全,更有效的技术的需求尚未得到满足
将基因组编辑机器递送到体内疾病相关的体细胞和组织中。虽然Adeno-
相关病毒(AV)载体能够在体内递送具有高度编辑的CRISPR/Cas9系统
尽管它们具有有限的包装能力,缺乏靶向细胞/组织的特异性,并且可以诱导
由于Cas9的持续表达导致的遗传毒性和免疫应答。此外,大多数非病毒方法
使用全身施用体内递送CRISPR/Cas9仍然无效。解决这些
面对挑战,我们开发了Velcro AAV平台-插入亮氨酸拉链(LZ)的AAV载体
策略性地在衣壳表面上,使得载体生产和转导效率最低
受影响然后LZ衔接子可用于蛋白质到衣壳上的模块化和通用连接,
例如细胞靶向纳米抗体或肽以及基因组编辑试剂。我们的核心假设是
Velcro AAV将提供改善的细胞靶向特异性和增加的包装能力,
从而影响转导效率,使得能够在体内进行更安全和更稳健的体细胞基因组编辑。在阶段
1(UG 3),将构建Velcro AAV载体,表征和优化用于基于纳米抗体的免疫原性。
内皮靶向(Aim 1a)和Cas9/BE蛋白附着(Aim 2a)。纳米抗体/核酸酶的作用
对病毒滴度和转导效率的附着进行定量。小鼠研究将在
目的1b、2b和2c测试Velcro AAV载体特异性靶向内皮的能力,
增加了用于体内基因编辑的包装能力。靶向特异性和基因编辑效率
Velcro AAV载体将在第2阶段(UH 3)通过Aim 3中的猪研究进一步确定。如果成功,则
拟议的研究将产生一种新的输送平台技术的强有力的临床前证明,
提供特异性细胞/组织靶向、更大的货物容量和瞬时核酸酶活性,
高效的体细胞基因组编辑。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Gang Bao其他文献
Gang Bao的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Gang Bao', 18)}}的其他基金
Deciphering unintended large gene modifications in gene editing for sickle cell disease
破译镰状细胞病基因编辑中意外的大基因修饰
- 批准号:
10720685 - 财政年份:2023
- 资助金额:
$ 75.82万 - 项目类别:
Precision mapping of regulatory causal variants by expression CROPseq
通过表达 CROPseq 精确绘制调控因果变异
- 批准号:
10095869 - 财政年份:2021
- 资助金额:
$ 75.82万 - 项目类别:
Precision mapping of regulatory causal variants by expression CROPseq
通过表达 CROPseq 精确绘制调控因果变异
- 批准号:
10557093 - 财政年份:2021
- 资助金额:
$ 75.82万 - 项目类别:
Precision mapping of regulatory causal variants by expression CROPseq
通过表达 CROPseq 精确绘制调控因果变异
- 批准号:
10341085 - 财政年份:2021
- 资助金额:
$ 75.82万 - 项目类别:
HBB gene-editing for treating sickle cell disease
HBB 基因编辑治疗镰状细胞病
- 批准号:
10609477 - 财政年份:2020
- 资助金额:
$ 75.82万 - 项目类别:
Addressing safety issues by quantify large deletions and chromosomal rearrangements in HBB gene editing
通过量化 HBB 基因编辑中的大缺失和染色体重排来解决安全问题
- 批准号:
10087778 - 财政年份:2020
- 资助金额:
$ 75.82万 - 项目类别:
HBB gene-editing for treating sickle cell disease
HBB 基因编辑治疗镰状细胞病
- 批准号:
10392986 - 财政年份:2020
- 资助金额:
$ 75.82万 - 项目类别:
Velcro AAV Vector for tissue-specific delivery of genome editing reagents with enhanced cargo capacity
Velcro AAV Vector 用于基因组编辑试剂的组织特异性递送,具有增强的负载能力
- 批准号:
9810928 - 财政年份:2019
- 资助金额:
$ 75.82万 - 项目类别:
Velcro AAV Vector for tissue-specific delivery of genome editing reagents with enhanced cargo capacity
Velcro AAV Vector 用于基因组编辑试剂的组织特异性递送,具有增强的负载能力
- 批准号:
10231050 - 财政年份:2019
- 资助金额:
$ 75.82万 - 项目类别:
Targeted Gene Therapy of Heart Failure Post Myocardial Infarction
心肌梗死后心力衰竭的靶向基因治疗
- 批准号:
9900055 - 财政年份:2018
- 资助金额:
$ 75.82万 - 项目类别:
相似海外基金
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
- 批准号:
BB/Z514391/1 - 财政年份:2024
- 资助金额:
$ 75.82万 - 项目类别:
Training Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
- 批准号:
2312555 - 财政年份:2024
- 资助金额:
$ 75.82万 - 项目类别:
Standard Grant
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
- 批准号:
2327346 - 财政年份:2024
- 资助金额:
$ 75.82万 - 项目类别:
Standard Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
- 批准号:
ES/Z502595/1 - 财政年份:2024
- 资助金额:
$ 75.82万 - 项目类别:
Fellowship
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
- 批准号:
ES/Z000149/1 - 财政年份:2024
- 资助金额:
$ 75.82万 - 项目类别:
Research Grant
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
- 批准号:
23K24936 - 财政年份:2024
- 资助金额:
$ 75.82万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
- 批准号:
2901648 - 财政年份:2024
- 资助金额:
$ 75.82万 - 项目类别:
Studentship
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
- 批准号:
488039 - 财政年份:2023
- 资助金额:
$ 75.82万 - 项目类别:
Operating Grants
New Tendencies of French Film Theory: Representation, Body, Affect
法国电影理论新动向:再现、身体、情感
- 批准号:
23K00129 - 财政年份:2023
- 资助金额:
$ 75.82万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The Protruding Void: Mystical Affect in Samuel Beckett's Prose
突出的虚空:塞缪尔·贝克特散文中的神秘影响
- 批准号:
2883985 - 财政年份:2023
- 资助金额:
$ 75.82万 - 项目类别:
Studentship